Biologics as countermeasures for acute radiation syndrome: where are we now?

Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): A review

(2015) Vijay K. Singh et al.   CYTOKINE

Radiation countermeasure agents: an update (2011 – 2014)

(2014) Vijay K Singh et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

A Basic Fibroblast Growth Factor Analog for Protection and Mitigation against Acute Radiation Syndromes

(2014) Kate Casey-Sawicki et al.   HEALTH PHYSICS

Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation

(2014) Zoya Gluzman-Poltorak et al.   Journal of Hematology & Oncology

Insulin-Like Growth Factor 1 Mitigates Hematopoietic Toxicity After Lethal Total Body Irradiation

(2012) Dunhua Zhou et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice

(2012) Jimmy Rotolo et al.   JOURNAL OF CLINICAL INVESTIGATION

Myeloid Progenitors: A Radiation Countermeasure that is Effective when Initiated Days after Irradiation

(2012) Vijay K Singh et al.   RADIATION RESEARCH

Filgrastim Improves Survival in Lethally Irradiated Nonhuman Primates

(2012) Ann M. Farese et al.   RADIATION RESEARCH

First Global Consensus for Evidence-Based Management of the Hematopoietic Syndrome Resulting From Exposure to Ionizing Radiation

(2011) Nicholas Dainiak et al.   Disaster Medicine and Public Health Preparedness

An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

(2008) L. G. Burdelya et al.   SCIENCE